People: Cardica Inc (CRDC.OQ)
CRDC.OQ on NASDAQ Stock Exchange Global Market
1.20USD
10:31am EDT
1.20USD
10:31am EDT
Price Change (% chg)
$0.01 (+0.84%)
$0.01 (+0.84%)
Prev Close
$1.19
$1.19
Open
$1.21
$1.21
Day's High
$1.21
$1.21
Day's Low
$1.20
$1.20
Volume
2,953
2,953
Avg. Vol
12,841
12,841
52-wk High
$1.96
$1.96
52-wk Low
$0.67
$0.67
Summary
| Name | Age | Since | Current Position |
|---|---|---|---|
Kevin Larkin |
63 | 2007 | Independent Chairman of the Board |
Bernard Hausen |
52 | 2000 | President, Chief Executive Officer, Chief Medical Officer, Director |
Robert Newell |
64 | 2008 | Chief Financial Officer, Vice President - Finance |
Frederick Bauer |
58 | 2008 | Vice President - Operations |
Christopher Littel |
56 | 2011 | Vice President - Sales and Marketing |
Bryan Knodel |
52 | 2005 | Vice President - Research & Development |
Richard Powers |
68 | 2005 | Independent Director |
Jeffrey Purvin |
60 | 2006 | Independent Director |
John Simon |
58 | 2001 | Independent Director |
William Younger |
63 | 2000 | Independent Director |
Biographies
| Name | Description |
|---|---|
Kevin Larkin |
Mr. Kevin T. Larkin serves as Independent Chairman of the Board of Cardica, Inc. He has been a director since December 2005 and was elected Chairman of the Board in January 2007. Mr. Larkin has been President, Chief Executive Officer and a director of TherOx, a medical device company, since May 2001. From July 1998 until April 2001, Mr. Larkin was President and Chief Executive Officer of CardioVasc, a medical device company. Mr. Larkin also has held senior sales and marketing management positions with Ventritex, Medtronic and Cordis. |
Bernard Hausen |
Dr. Bernard A. Hausen, M.D., Ph.D., serves as President, Chief Executive Officer, Chief Medical Officer, Director of Cardica Inc. Dr. Hausen co-founded Cardica in October 1997 and has served as a director and the company's Chief Medical Officer since inception. Dr. Hausen received a medical degree from Hannover Medical School in Germany in 1988 and was trained there as a general and cardiothoracic surgeon. Upon completion of his training, he received a Ph.D. degree in Medical Physiology in 1999. From 1996 to 2000, he was employed as a Senior Research Scientist in the Laboratory for Transplantation Immunology of the Department of Cardiothoracic Surgery at Stanford University. Until Dr. Hausen became the company's full-time employee in October 2000, he remained responsible for all surgery-related research in that laboratory. |
Robert Newell |
Mr. Robert Y. Newell serves as Chief Financial Officer, Vice President - Finance of Cardica Inc. He has been the company's Vice President, Finance and Chief Financial Officer since March 2003 and was Vice President, Finance and Operations, from July 2005 to July 2008. From January 2000 to February 2003 he was Vice President, Finance and Chief Financial Officer for Omnicell, Inc., a hospital supply and medication management company. Mr. Newell holds a B.A. degree in Mathematics from the College of William & Mary and an M.B.A. degree from the Harvard Business School. |
Frederick Bauer |
Mr. Frederick M. Bauer serves as Vice President - Operations of Cardica Inc. He joined Cardica as the company's Vice President of Operations in July 2008. From August 2005 to June 2008, he was President and Owner of 3RLatex, LLC, a containment, transportation and recycling company for the construction industry and from November 2002 to November 2005, he was general manager of Amazon Environmental, a latex paint recycling company. From October 1996 to November 2001, he was Vice President Operations for the Cardiac Surgery division and Vice President Operations for the Perfusion Systems division of Medtronic, Inc., a medical device company. He also held a number of operations and engineering executive positions with Baxter Healthcare International, a healthcare company, from 1981 to 1996. He currently serves as a member of the board of the Orange County ARC, a non-profit servicing 700 developmentally disabled adults. Mr. Bauer holds a B.S. degree in Civil Engineering from the University of Detroit Mercy. |
Christopher Littel |
Mr. Christopher J. Littel has been appointed as Vice President - Sales and Marketing of Cardica Inc. He joined Cardica as the company's Vice President, Sales and Marketing, in November 2011. From April 2010 to October 2011, he was Vice President , Marketing and Chief Operating Officer of Neurowave Medical Technologies a privately held medical device company. From August 1994 to April 2010, he held various senior marketing and product development positions with Ethicon Endo-Surgery, a division of Johnson & Johnson, a diversified healthcare company. From 1978 to 1994, he was an officer in the United States Army. Mr. Littel holds a B.S. degree in Engineering from the United States Military Academy at West Point and an M.A. in International Economics & International Relations from Johns Hopkins University. |
Bryan Knodel |
Mr. Bryan D. Knodel, Ph.D., serves as Vice President - Research and Development of Cardica Inc. He joined Cardica as the company's Vice President of Research and Development in July 2005. Since January 1998, he has been president of Bryan D. Knodel, Inc., a consulting firm specializing in medical device design and product development. From April 2001 until June 2005, Mr. Knodel consulted for the company in product development. From 1992 to 1997, he was a principal engineer with Ethicon Endo-Surgery, a Johnson & Johnson company developing medical devices for less invasive surgery. Mr. Knodel holds B.S., M.S. and Ph.D. degrees in Mechanical Engineering from the University of Illinois. |
Richard Powers |
Mr. Richard P. Powers is Independent Director of Cardica Inc. He has been a director and chairman of the company's Audit Committee since October 2005. Since November 2010, Mr. Powers has served as Executive Vice President of VisionCare Ophthalmic Technologies, Inc., a privately held medical device company. From September 2009 to October 2010, Mr. Powers was a consultant to several medical device companies. From June 2008 to August 2009, Mr. Powers was President and Chief Executive Officer of Aspire Medical Inc., a privately held medical device company. From October 2001 to March 2008, Mr. Powers was Vice President and Chief Financial Officer of Anesiva, Inc. (formerly Corgentech Inc.), a publicly held biotechnology company. From February 1996 to August 2000, Mr. Powers served as Executive Vice President and Chief Financial Officer of CardioGenesis Corporation, a medical device company. From January 1981 to August 1995, Mr. Powers held a number of senior management positions at Syntex Corporation, a biopharmaceutical company, including Senior Vice President and Chief Financial Officer. Mr. Powers holds a B.S. degree in Accounting from Canisius College and an M.B.A. degree from the University of Rochester, New York. Mr. Powers was a member of the board of directors of HemoSense, Inc., a medical diagnostics company, from September 2005 to November 2008. |
Jeffrey Purvin |
Mr. Jeffrey L. Purvin is Independent Director of Cardica, Inc. He has been a director since August 2006. Mr. Purvin is the chief executive officer of Response Biomedical (TSK: RBM, OTCBB: RPBIF), which manufactures and sells world-wide in-vitro diagnostic tests and readers, and has been there since May 2012. From November 2006 to December 2012, Mr. Purvin was chairman and chief executive officer of Calibra Medical, Inc., a privately held company developing medical devices for the treatment of diabetes. Calibra was acquired by Johnson & Johnson in July 2012. Mr. Purvin was the chairman and chief executive officer of Metrika, Inc., a privately held manufacturer and marketer of disposable diabetes monitoring products, from November 2004 until July 2006, when the company was sold to the Bayer Group. Prior to Metrika, Mr. Purvin was President of the Interventional Products Division of Datascope Corporation, a diversified public medical device company (since acquired by Maquet, Inc.), from April 2001 until October 2004. Before Datascope, Mr. Purvin spent more than 20 years at GlaxoSmithKline, where he concluded his service as Vice President, General Manager. Mr. Purvin earned his M.B.A. in marketing from The Wharton School, University of Pennsylvania and his BA in psychology from Brown University. |
John Simon |
Dr. John Simon, Ph.D., is Independent Director of Cardica, Inc. He has been a director since June 2001. Mr. Simon is a Managing Director of the investment banking firm, Allen & Company LLC, where he has been employed for over 25 years. He was a member of the board of directors for Neurogen Corporation, a biopharmaceutical company, from 1993 to December 2009, and continues to serve on the boards of several privately held companies. Mr. Simon holds a B.S. degree in Chemistry from The College of William & Mary, a Ph.D. degree in Chemical Engineering from Rice University, and both an M.B.A. degree in finance and a J.D. degree from Columbia University. Mr. Simon has broad experience in capital markets, corporate and financial strategy and has been instrumental in advising Cardica and the Board on raising the capital required to pursue Cardica’s goals. |
William Younger |
Mr. William H. Younger, Jr., is Independent Director of Cardica, Inc. He has been a director since August 2000. Mr. Younger is a managing director of the general partner of Sutter Hill Ventures, a venture capital firm, where he has been employed since 1981. Mr. Younger holds a B.S. degree in Electrical Engineering from the University of Michigan and an M.B.A. degree from Stanford University. Mr. Younger was a member of the board of directors of Vitria Technology, Inc., a software company, from 1997 to November 2005, and Omnicell, Inc., a company specializing in medication and supply management for hospitals, from 1992 to May 2012. Having served on the Board for more than 10 years, Mr. Younger provides both a historic understanding of Cardica’s strategies, as well as provides board continuity. |
Basic Compensation
| Name | Fiscal Year Total |
|---|---|
Kevin Larkin |
-- |
Bernard Hausen |
481,930 |
Robert Newell |
308,899 |
Frederick Bauer |
393,175 |
Christopher Littel |
-- |
Bryan Knodel |
408,399 |
Richard Powers |
-- |
Jeffrey Purvin |
-- |
John Simon |
-- |
William Younger |
-- |
As Of 29 Jun 2012
Options Compensation
| Name | Options | Value |
|---|---|---|
Kevin Larkin |
0 | 0 |
Bernard Hausen |
208,332 | 927,060 |
Robert Newell |
72,666 | 282,490 |
Frederick Bauer |
0 | 0 |
Christopher Littel |
0 | 0 |
Bryan Knodel |
97,947 | 49,244 |
Richard Powers |
0 | 0 |
Jeffrey Purvin |
0 | 0 |
John Simon |
0 | 0 |
William Younger |
0 | 0 |
| Name | Shares Traded | Price |
|---|---|---|
SUTTER HILL VENTURES |
981,736 | $1.05 |
YOUNGER WILLIAM H JR |
262,942 | $1.05 |
SPEISER MICHAEL L |
2,370 | $1.05 |
COXE TENCH C |
63,374 | $1.05 |
DYCKERHOFF STEFAN A |
981,736 | $1.05 |
SHEEHAN ANDREW T |
981,736 | $1.05 |
BIRD JEFFREY W |
38,166 | $1.05 |
BIRD JEFFREY W |
981,736 | $1.05 |
COXE TENCH C |
63,374 | $1.05 |
SWEET DAVID E |
9,837 | $1.05 |
PULLARA SAMUEL J III |
981,736 | $1.05 |
SPEISER MICHAEL L |
981,736 | $1.05 |
BAKER G LEONARD JR |
52,899 | $1.05 |
ANDERSON DAVID L |
91,966 | $1.05 |
GAITHER JAMES C |
23,149 | $1.05 |
WHITE JAMES N |
981,736 | $1.05 |
ANDERSON DAVID L |
981,736 | $1.05 |
BAKER G LEONARD JR |
43,135 | $1.05 |
PULLARA SAMUEL J III |
18,433 | $1.05 |
YOUNGER WILLIAM H JR |
981,736 | $1.05 |
BAKER G LEONARD JR |
981,736 | $1.05 |
COXE TENCH C |
63,374 | $1.05 |
WHITE JAMES N |
45,845 | $1.05 |
GAITHER JAMES C |
23,149 | $1.05 |
GAITHER JAMES C |
981,736 | $1.05 |

